BioHealth News Archive
NIH Launches Clinical Trial to Study Hydroxychloroquine Efficacy in COVID-19
The lack of treatment options for COVID-19 patients, potential promise in repurposing drugs, and controversy surrounding the anti-malarial drug hydroxychloroquine have created a storm…
Read MoreWith $306M for serology research, NCI mobilizes labs, academic centers, grantees, contractors, and SBIR – The Cancer Letter
The NCI Board of Scientific Advisors has approved concepts for an RFA and an RFP to support research in serological testing. The plan presented…
Read MoreEntrepreneurship in Baseball – Twinkie Town
At North Dakota State this semester, I took a course titled “Economics of Entrepreneurship”. It was a deep dive into economic theory with a…
Read MoreCouncil funded grants support local businesses to pivot to PPE, emergency response – Hans Riemer, CouncilmemberHans Riemer, Councilmember
ROCKVILLE, Md., May 15, 2020—Supported by a special appropriation by the Council, the Montgomery County Economic Development Corporation (MCEDC) has awarded 25 local businesses…
Read MoreVaccine Company Novavax Gets $388 Million Grant For Coronavirus Vaccine
TOPLINE Public vaccine company Novavax announced today that it will receive up to $388 million from the Coalition for Epidemic Preparedness (CEPI) to continue…
Read MoreSilicon Valley Super Angel Dr. Faz Bashi, M.D. joins Rich Bendis Virtually for a New Episode of BioTalk
Silicon Valley Super Angel Angel Investor, Dr. Faz Bashi, M.D., joins BioTalk from the West Coast to discuss the Venture Capital, partnerships and staying…
Read MoreMaryland Biotechnology Investment Incentive Tax Credit (BIITC) Program Still on but Delayed until mid-August
As a result of the ongoing COVID-19 pandemic and the impact on both government and business operations, under the authority of executive order, the…
Read MoreFina Biosolutions Awarded $289,000 from NIAID to Develop Carrier Protein for Conjugate Vaccines
Rockville, Maryland’s Fina Biosolutions recently was awarded an SBIR grant to develop a genetically detoxified tetanus toxin as a carrier protein for conjugate vaccines. The NIAID…
Read MoreThe importance of children’s hospitals during the COVID-19 pandemic | TheHill
Early reports of the COVID-19 pandemic, created an initial widespread impression that children were not severely affected by the virus. This understanding was framed…
Read MoreRace for a Coronavirus Vaccine
About 48 hours after a Seattle woman received the first dose of an experimental vaccine against SARS-CoV-2, scientists in China—not to be outdone—announced that…
Read MoreHow a Johns Hopkins Professor and Her Chinese Students Tracked Coronavirus – WSJ
Lauren Gardner, an associate engineering professor at Johns Hopkins University, was sitting in a school coffee shop with two graduate students in January, chatting…
Read MoreUMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System | UM Ventures
BALTIMORE, May 7, 2020 /PRNewswire/ -- Pumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to Lyv, a cutting-edge clinical decision support system designed to help…
Read MoreUM Ventures-Backed Breethe Acquired by Abiomed – University of Maryland, Baltimore
Last week, Abiomed acquired Baltimore-based startup Breethe for its innovative respiratory device. Breethe is a startup out of the University of Maryland, Baltimore (UMB) that…
Read MoreBiobuzz Directory – Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage
Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans COLUMBIA, Md., May 4, 2020 Intralytix, Inc. announced today that…
Read MoreStart-up hits $1 billion virtually as virus shifts Silicon Valley riches
When VAST Data hit the hallmark of this era’s Silicon Valley start-up boom last month, a $1 billion so-called unicorn valuation, it didn’t come…
Read More